A recent study by Caetano and colleagues demonstrated that female animals, in the context of Il-6 and Stat3 pro-tumor inflammatory signaling, displayed differential anti-lung cancer immune responses, evidenced by levels of tumor infiltrating lymphocytes, compared with males (41). The gene discussed is STAT3; the disease is lung cancer.